These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3891277)

  • 1. Personal adventures in biopharmaceutical research during the 1953-1984 years.
    Swintosky JV
    Drug Intell Clin Pharm; 1985 Apr; 19(4):265-76. PubMed ID: 3891277
    [No Abstract]   [Full Text] [Related]  

  • 2. Gordon L. Amidon: Very Sustained Drug Absorption.
    Donovan MD; Polli JE; Langguth P; Tamai I; Vig B; Yu LX
    J Pharm Sci; 2015 Sep; 104(9):2650-63. PubMed ID: 26053319
    [No Abstract]   [Full Text] [Related]  

  • 3. [Age-related aspects of pharmacokinetics (a review of the literature)].
    Bezverkhaia IS; Zapadniuk VI
    Farmakol Toksikol; 1980; 43(1):115-9. PubMed ID: 6991280
    [No Abstract]   [Full Text] [Related]  

  • 4. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic availability and therapeutic equivalence.
    Arnold JD; Sicé J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfer functions obtained by the rule of corresponding fractional areas.
    Dost FH; von Hattingberg HM
    Eur J Clin Pharmacol; 1971 Sep; 3(4):252-4. PubMed ID: 5151310
    [No Abstract]   [Full Text] [Related]  

  • 7. Calculating absorption rate constants for drugs with incomplete availability.
    Leeson LJ; Weintraub H
    J Pharm Sci; 1973 Dec; 62(12):1936-41. PubMed ID: 4762161
    [No Abstract]   [Full Text] [Related]  

  • 8. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.
    Lennernäs H
    Mol Pharm; 2014 Jan; 11(1):12-23. PubMed ID: 24206063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of pharmacokinetics.
    Wagner JG
    Pharmacol Ther; 1981; 12(3):537-62. PubMed ID: 7025032
    [No Abstract]   [Full Text] [Related]  

  • 12. A history of biopharmaceutics in the Food and Drug Administration 1968-1993.
    Skelly JP
    AAPS J; 2010 Mar; 12(1):44-50. PubMed ID: 19936940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physicochemical and pharmacokinetic bases for the biopharmaceutical evaluation of drug biological availability in pharmaceutical formulations.
    Garrett ER
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():1-29. PubMed ID: 5316401
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Bioavailability, bioequivalence and bias.
    Leopold IH
    Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003
    [No Abstract]   [Full Text] [Related]  

  • 17. Calculation of absorption rate constants for drugs with incomplete availability.
    Perrier D; Gibaldi M
    J Pharm Sci; 1973 Feb; 62(2):225-8. PubMed ID: 4686394
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies.
    Smyth RD; Hottendorf GH
    Toxicol Appl Pharmacol; 1980 Apr; 53(2):179-95. PubMed ID: 7394763
    [No Abstract]   [Full Text] [Related]  

  • 19. The utility of pharmacokinetics to the pharmaceutical industry.
    Nelson RL
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):565-9. PubMed ID: 977797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
    J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.